Peptide Purification

Size-Exclusion Chromatography (SEC)  

SEC separates molecules based on differences in hydrodynamic volume, using stationary phases of porous gel media (e.g., Sephadex, Superdex) with pore sizes that sieve molecules of different molecular weights. Smaller peptides enter the gel pores and have longer retention times, while larger molecules pass through the column directly, achieving separation in the order of decreasing molecular weight. This method primarily removes peptide aggregates, multimers, or separates impurities with molecular weight differences >10 kDa, often used as a polishing step.

Affinity Chromatography (AC)

AC separates target molecules through specific binding to ligands on the stationary phase, which are conjugated with specific ligands (e.g., antibodies, metal ions, biotin). It selectively captures recombinant peptides with tags (e.g., His-tag, GST-tag) or natural peptides with specific domains. Changing elution conditions (e.g., low pH, competitive ligands) disrupts specific binding, enabling efficient enrichment of target peptides. This is a key technique for initial purification of recombinantly expressed peptides.

Hydrophobic Interaction Chromatography (HIC)  

HIC separates peptides based on reversible interactions between hydrophobic groups of solutes and hydrophobic ligands (e.g., phenyl, butyl) on the surface of hydrophilic supports in high-salt environments. High-concentration salt solutions (e.g., ammonium sulfate) promote exposure of peptide hydrophobic regions and binding to ligands; gradually decreasing salt concentration weakens these interactions, eluting peptides with different hydrophobicities sequentially. Suitable for separating peptides in high-salt systems, it complements reversed-phase chromatography.

cGMP-Compliant Quality Control System  

Throughout the peptide synthesis and purification process, strict adherence to current Good Manufacturing Practice (cGMP) is required, ensuring high purity and quality uniformity of final products through systematic quality management. All chemical synthesis and analytical operations must establish comprehensive documentation, covering key nodes such as raw material procurement, process parameters, intermediate testing, and finished product release. Standardized testing methods and quality specifications are pre-defined, with method validation (e.g., specificity, precision, recovery) ensuring process controllability and data traceability. In the purification stage of peptide synthesis, cGMP compliance is particularly stringent, as it directly determines the quality attributes of final products as a critical downstream step. Guided by the Quality by Design (QbD) concept, key process steps and parameter ranges are clearly defined, including column loading capacity, mobile phase flow rate, column performance indicators, in-line cleaning procedures (CIP), elution buffer composition, intermediate storage time limits, and fraction combination criteria. Process qualification (PQ) determines operational windows and control limits for parameters, ensuring repeatable purification within predefined ranges and balancing impurity removal efficiency with target peptide recovery. The quality control system integrates real-time process monitoring and offline testing, establishing a mass spectrometry framework for related substances analysis.

Cocer Peptides adheres to the industry’s strictest synthesis and purification standards. Through dedication to these standards, it delivers peptides with purities exceeding 99%, suitable for any research or application.